Patents by Inventor Arti Mahendra Prakash Kanjolia

Arti Mahendra Prakash Kanjolia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR KNOCKING OUT C5
    Publication number: 20240415980
    Abstract: Guide RNAs and CRISPR/Cas systems targeting a C5 locus or gene, lipid nanoparticles or viral vectors comprising such guide RNAs or CRISPR/Cas systems, and cells or animals comprising such guide RNAs or systems are provided. Methods of modifying or knocking down or knocking out a C5 locus or gene using the CRISPR/Cas systems are also provided, as well as use of the CRISPR/Cas systems in prophylactic and therapeutic applications for treatment and/or prevention of a disease, disorder, or condition associated with C5 and/or for ameliorating at least one symptom associated with such disease, disorder, or condition.
    Type: Application
    Filed: October 28, 2022
    Publication date: December 19, 2024
    Inventors: Kishor Devalaraja-Narashimha, Lori Morton, Evangelos Pefanis, Suzanne Hartford, Arti Mahendra Prakash Kanjolia, Sarah Hesse
  • Compositions and methods for TTR gene editing and treating ATTR amyloidosis
    Patent number: 11965165
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Grant
    Filed: December 9, 2022
    Date of Patent: April 23, 2024
    Assignee: Intellia Therapeutics, Inc.
    Inventors: Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent
    Publication number: 20240124897
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Application
    Filed: July 31, 2023
    Publication date: April 18, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Yong Chang, Seth C. Alexander, Kristy M. Wood, Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Compositions and methods for TTR gene editing and treating ATTR amyloidosis
    Patent number: 11795460
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Grant
    Filed: December 9, 2022
    Date of Patent: October 24, 2023
    Assignee: Intellia Therapeutics, Inc.
    Inventors: Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
    Publication number: 20230257747
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Application
    Filed: December 9, 2022
    Publication date: August 17, 2023
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Methods of in Vitro Cell Delivery
    Publication number: 20230183753
    Abstract: Compositions and methods for multiplex delivery and gene editing in vitro are provided.
    Type: Application
    Filed: October 27, 2022
    Publication date: June 15, 2023
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Pooja Kyatsandra Narendra, Sean Michael Burns, Paula Gutierrez Martinez, Arti Mahendra Prakash Kanjolia, Anthony Monti, Aaron Prodeus, Mohamed Simo Arredouani, Özgün Kiliç, Reed Walker LaRiviere, Palak Sushil Sharma, Eleni Stampouloglou, Qingzhan Zhang
  • Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
    Publication number: 20230118592
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Application
    Filed: December 9, 2022
    Publication date: April 20, 2023
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent
    Publication number: 20230044994
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Application
    Filed: September 27, 2021
    Publication date: February 9, 2023
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Yong Chang, Seth C. Alexander, Kristy M. Wood, Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps
  • Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use Thereof
    Publication number: 20230035659
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene in combination with administration of a corticosteroid are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), in which a guide RNA and a corticosteroid are administered, are provided.
    Type: Application
    Filed: September 27, 2021
    Publication date: February 2, 2023
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Yong CHANG, Seth C. ALEXANDER, Kristy M. WOOD, Arti Mahendra Prakash KANJOLIA, Shobu ODATE, Jessica Lynn SEITZER, Reynald Michael LESCARBEAU, Walter STRAPPS
  • Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
    Publication number: 20200248180
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
    Type: Application
    Filed: March 24, 2020
    Publication date: August 6, 2020
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Arti Mahendra Prakash Kanjolia, Shobu Odate, Jessica Lynn Seitzer, Reynald Michael Lescarbeau, Walter Strapps